CONTACT US
/
ENGLISH
/
ADMIN
°øµ¿¿¬±¸/ÆÄÆ®³Ê¸µ
biz@peptron.com
ÆéŸÀ̵å ÁÖ¹®
order@peptron.co.kr
ȸ»ç¼Ò°³
ȸ»ç°³¿ä
±â¾÷°¡Ä¡/ºñÀü
CEOÀλ縻
¿¬Çõ
À±¸®°æ¿µ
È«º¸µ¿¿µ»ó
ã¾Æ¿À½Ã´Â±æ
R&D
±â¹Ý±â¼ú
°³¹ßÁ¦Ç°
°øµ¿¿¬±¸/ÆÄÆ®³Ê¸µ
ÁÖ¹®Çü ÆéŸÀ̵å ÇÕ¼º
ÆéŸÀ̵å ÇÕ¼º ¼ºñ½º
°ßÀû ¹®ÀÇ
Peptide Handbook
ÆéŸÀ̵å Ȱ¿ëÇöȲ
FAQ
Community
°øÁö
NEWS
°ø°í
ä¿ë
ȸ»ç¼Ò°³
ȸ»ç°³¿ä
±â¾÷°¡Ä¡/ºñÀü
CEOÀλ縻
¿¬Çõ
À±¸®°æ¿µ
ã¾Æ¿À½Ã´Â±æ
R&D
±â¹Ý±â¼ú
°³¹ßÁ¦Ç°
°øµ¿¿¬±¸/ÆÄÆ®³Ê¸µ
ÁÖ¹®Çü ÆéŸÀ̵å ÇÕ¼º
ÆéŸÀ̵å ÇÕ¼º ¼ºñ½º
°ßÀû ¹®ÀÇ
Peptide Handbook
ÆéŸÀ̵å Ȱ¿ëÇöȲ
FAQ
Community
°øÁö
NEWS
°ø°í
ä¿ë
ä¿ë
ÁÖ¹®Çü ÆéŸÀ̵å ÇÕ¼º
ÆéŸÀ̵å ÇÕ¼º ¼ºñ½º
°ßÀû ¹®ÀÇ
Peptide Handbook
ÆéŸÀ̵å Ȱ¿ëÇöȲ
FAQ
Community
ÁÖ¹®Çü ÆéŸÀ̵å ÇÕ¼º ¸Þ´º ¹Ù·Î°¡±â
ÁÖ¹®Çü ÆéŸÀ̵å ÇÕ¼º ¸Þ´º ¹Ù·Î°¡±â
ÆéŸÀ̵å ÇÕ¼º ¼ºñ½º
°ßÀû ¹®ÀÇ
Peptide Handbook
ÆéŸÀ̵å Ȱ¿ëÇöȲ
FAQ
Community
> ÁÖ¹®Çü ÆéŸÀ̵å ÇÕ¼º > ÆéŸÀ̵å Ȱ¿ëÇöȲ
ÆéŸÀ̵å Ȱ¿ëÇöȲ
ÆéÆ®·ÐÀÇ À̺¥Æ® ¼Ò½ÄÀ» ¾È³» µå¸³´Ï´Ù.
Total : 274 Page : ( 28/5 )
Á¦¸ñ
³»¿ë
NO
±ÛÁ¦¸ñ
ÀÛ¼ºÀÚ
ÀÛ¼ºÀÏÀÚ
÷ºÎ
Á¶È¸
234
Capillary electrophoresis-laser-induced fluorescence (CE-LIF..
°ü¸®ÀÚ
2020-03-12
543
233
The vicious cycle between transglutaminase 2 and reactive ox..
°ü¸®ÀÚ
2020-01-31
721
232
Gold binding peptide identified from microfluidic biopanning..
°ü¸®ÀÚ
2020-01-23
529
231
Multifront assault on antigen presentation by japanese encep..
°ü¸®ÀÚ
2020-01-15
529
230
Dual-site interactions of p53 protein transactivation domain..
°ü¸®ÀÚ
2020-01-15
728
229
Structural mechanism of the arrestin-3/JNK3 interaction
°ü¸®ÀÚ
2019-11-08
742
228
Identification of HLA-DR4-restricted immunogenic peptide der..
°ü¸®ÀÚ
2019-11-06
600
227
Identification of HLA-A2-restricted immunogenic peptides der..
°ü¸®ÀÚ
2019-11-06
530
226
Innate-like cytotoxic function of bystander-activated CD8+ T..
°ü¸®ÀÚ
2019-10-29
978
225
RNAi-mediated silencing of TNF-¥á converting enzyme to down-..
°ü¸®ÀÚ
2019-09-10
701
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[¢º]
[28]